Back to today’s briefing

Story perspectives

Nucleus Secures $14M for AI-Driven Genetic Testing Expansion

1/30/2025

50 5

Summary

Story summary

Nucleus, a trailblazing consumer health startup, has raised $14 million in Series A funding, bringing its total to nearly $32 million. With support from notable investors like Alexis Ohanian and Peter Thiel, Nucleus provides clinical-grade genetic testing for over 800 diseases. Its recent acquisition of Cambrean boosts its AI-driven platform, merging wearable data for richer health insights.

1 of 1

Story summary

Nucleus, a trailblazing consumer health startup, has raised $14 million in Series A funding, bringing its total to nearly $32 million. With support from notable investors like Alexis Ohanian and Peter Thiel, Nucleus provides clinical-grade genetic testing for over 800 diseases. Its recent acquisition of Cambrean boosts its AI-driven platform, merging wearable data for richer health insights.